Lipid parameters for measuring risk of cardiovascular disease. - Wikidata - awgldk - TriplyDB

Lipid parameters for measuring risk of cardiovascular disease.

Lipid parameters for measuring risk of cardiovascular disease.

http://www.wikidata.org/entity/Q37833906

about

Leukotrienes as modifiers of preclinical atherosclerosis?Lipid-related markers and cardiovascular disease prediction.Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations.Apolipoprotein C-I Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Population.The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts.Association between lipid ratios and insulin resistance in a Chinese population.Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease.Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.The Human Blood Metabolome-Transcriptome Interface Associations of lipid levels susceptibility loci with coronary artery disease in Chinese population.Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.Prevalence of Vitamin D Deficiency in Singapore: Its Implications to Cardiovascular Risk Factors.Sleep apnea is independently associated with peripheral arterial disease in the Hispanic Community Health Study/Study of Latinos.Gender-specific pathway differences in the human serum metabolome.Relationships between genetic polymorphisms of E670G in PCSK9 gene and coronary artery disease: a meta-analysis Genetic variants of SLC17A1 are associated with cholesterol homeostasis and hyperhomocysteinaemia in Japanese men.A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.Pathobiology of obstructive sleep apnea-related dyslipidemia: focus on the liver.Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population.Effects of Cyclo-His-Pro-enriched yeast hydrolysate on blood glucose levels and lipid metabolism in obese diabetic ob/ob mice.Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.Particle numbers of lipoprotein subclasses and arterial stiffness among middle-aged men from the ERA JUMP study.Relationship of lipid and lipoprotein ratios with coronary severity in patients with new on-set coronary artery disease complicated with type 2 diabetics.Atherogenic dyslipidemia.Chronic vitamin A-enriched diet feeding regulates hypercholesterolaemia through transcriptional regulation of reverse cholesterol transport pathway genes in obese rat model of WNIN/GR-Ob strain.Veganism Is a Viable Alternative to Conventional Diet Therapy for Improving Blood Lipids and Glycemic Control.The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management.Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes.The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis.Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants.Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals.Epigenetics of Lipid Phenotypes.Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics.

P2860

Q27025129-0ADA2442-C85D-4E46-BF1B-ED2747F3F1FF Q28654304-E729EE21-0292-4DEC-A0B9-76A918BE967A Q30419436-A2371381-0D88-47DE-BE6E-F1216B335DF0 Q30423388-DC4DEAEA-DE88-4F80-8EBD-B70F15F7FC16 Q33748703-68B63990-F64C-4E11-9D36-891564CD7897 Q33776214-218DF1E0-58F5-4379-9D6C-CA810C630198 Q34205523-EFB95F09-0D77-4B08-AB12-D12629311BA5 Q34544753-16608538-BF9E-4FD2-B906-79DBCB9C6A5F Q35032010-C9259695-71C3-4606-8944-8D9E5C835074 Q35124567-971F3B85-FA38-4980-9BC2-71CED0365850 Q35325687-FDFD2F92-D5FC-48D1-A1B6-1EC8F5A6FA78 Q35560513-E72C3395-0B55-449C-9AF5-9DE74259ADF6 Q35579449-B6783A03-666E-4B7B-BA66-C2A25912BED4 Q35666911-C4F684A7-212B-4DC5-BD83-2E260EEF401A Q35888857-CD12D79B-F581-4ACF-82B6-5E50EC5F5A3E Q35898244-F5309092-4DCC-4EB9-88BC-B99D4D06B02C Q35901347-9B803403-D43F-40A0-AD97-BDD1187BA759 Q35983719-222E2381-9952-4968-BEC4-CBF1E381747B Q36162318-9C621943-4533-48F0-8B12-4B64D18D1C0B Q36182994-53F93107-4F5E-4953-BC3D-1B9A9F17E8BF Q36242142-9E513B95-5D59-43B5-89CD-377C1375AF92 Q36536068-373AF32C-0110-445F-B48E-199998D47FF3 Q36546481-79901C38-8218-4BD7-9CEF-B4F77974B4B8 Q36664453-16AB0ACE-DF46-4355-86C7-10DA8C1FEC29 Q36760463-1F0D4601-895E-46E2-98F0-40C363B3BCBC Q37050968-E18FF1E6-B6C1-4C70-929C-653A0F3FBE08 Q37078689-0E146CDE-31B5-4F9E-B4CA-A953780521E5 Q37238855-0EF44764-AFA0-4743-836D-DD25B630AF2B Q37345232-0635C67F-E55F-46FE-B2B3-2D8611366B2F Q37413996-6C1F88B7-9DD2-407B-81B8-603C2B7F201E Q37550901-5FAC922E-8BFD-469A-A81F-B11FB6A26E08 Q38219695-98CB25FB-6D01-442F-AC79-87C237F904B8 Q38246002-C397953A-3785-412A-935D-893DBD10C5CD Q38287565-EECB88FD-43D8-4714-AB1B-4508EE2ECEDF Q38328260-341D5CB2-23FB-48D0-9E5E-5E3DAFAF798A Q38578940-6E3E76F2-A7A7-453C-BD4E-63FE3EE2F264 Q39068223-5E35E552-970F-4128-9E4D-A38994A9B308 Q39074820-7F147CB3-FA6E-4E7D-A96B-134F168B8253 Q39300247-81564372-0829-42D6-AA67-481D0E806099 Q39414910-2CD2C9DB-D231-4074-B596-9A19BEC38B1E

P2860

Lipid parameters for measuring risk of cardiovascular disease.

http://www.wikidata.org/entity/Q37833906

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lipid parameters for measuring risk of cardiovascular disease.

@en

Lipid parameters for measuring risk of cardiovascular disease.

@nl

type

label

Lipid parameters for measuring risk of cardiovascular disease.

@en

Lipid parameters for measuring risk of cardiovascular disease.

@nl

prefLabel

Lipid parameters for measuring risk of cardiovascular disease.

@en

Lipid parameters for measuring risk of cardiovascular disease.

@nl

P1433

Q37833906-808EC417-D126-4B16-B371-6F5F603AEC51

P1476

Q37833906-FA57208C-10FA-4909-850D-824F2D62469D

P2093

Q37833906-2CC8990A-0C52-4C7B-825C-2455C24B39FD

Q37833906-4FDA0753-9B50-4EC1-B5F0-306968503C26

Q37833906-C094C573-A65D-478B-A392-116478ADA35E

P2860

Q37833906-0266BE45-0A3A-4620-8FAD-CDF787F0BF53

Q37833906-03F3AD7C-5AD1-468F-8ECE-87381BB73FA8

Q37833906-0C7C8AC2-8B99-4214-AE59-5DE03958BD72

Q37833906-0EF5BFD6-A2D9-4B63-BA93-6BCCBA5BF984

Q37833906-0F8B9579-07CA-4994-A3D3-3F1E285E4815

Q37833906-11B615D4-6DFF-446A-B4FE-E339502A959C

Q37833906-133BF10F-0924-4D6D-82A7-A06E3A70C2A4

Q37833906-13678AC4-9005-416A-AD6C-40B8CEEE2D5A

Q37833906-1472AB6D-7B2F-4E54-9756-21E0C88E9588

Q37833906-1489D65F-DD6A-47B0-B589-CD2D3051CE6D

P2888

Q37833906-45267316-E748-4809-B81D-EF683A5D0F51

P304

Q37833906-9743713E-F6D4-426D-998D-FECDCEEDA767

P31

Q37833906-7F40F4C9-95CF-4FDA-83F8-D1A4DF96857E

P356

Q37833906-8CE87395-0C6E-4752-A591-35180C393A00

P407

Q37833906-05170DE4-1B10-48DE-B4D5-7C7029E016AE

P433

Q37833906-A3DE6666-1246-491A-A5A4-0D70B90B3EA8

P478

Q37833906-904DE4AB-FB60-490F-98A1-B8349CEC0C41

P577

Q37833906-D30A0665-095D-4E27-B41D-C221485920D7

P5875

Q37833906-8242C05B-89D4-4A77-8D86-9DC4A7AFC9A8

P6179

Q37833906-ED59766A-1DB4-41F2-931D-CAFC8C814AEB

P698

Q37833906-8C41DE3F-BC1B-4AB2-AE47-B70371E4EF85

P921

Q37833906-7F89214F-7EFE-415E-A407-07CB82BF04F7

P356

NRCARDIO.2010.223

P1433

Nature Reviews Cardiology

P1476

Lipid parameters for measuring risk of cardiovascular disease.

@en

P2093

Benoit J Arsenault

http://www.w3.org/2001/XMLSchema#string

John J P Kastelein

http://www.w3.org/2001/XMLSchema#string

S Matthijs Boekholdt

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Lipoprotein(a) as a cardiovascular risk factor: current status

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

Receptor-mediated control of cholesterol metabolism

P2888

nrcardio.2010.223

P304

197-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2010.223

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49800185

http://www.w3.org/2001/XMLSchema#string

P6179

1019366659

http://www.w3.org/2001/XMLSchema#string

P698

21283149

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease